Blood cancers, Myeloma
Results
Phase 1/2
This trial looked at a drug called panobinostat alongside bortezomib, thalidomide and dexamethasone for myeloma.
It was for people whose myeloma had come back or treatment had stopped working.
The trial was open for people to join between 2013 and 2014. The results were published in 2016.
Recruitment start: 31 January 2013
Recruitment end: 29 October 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jamie Cavenagh
Experimental Cancer Medicine Centre (ECMC)
Myeloma UK
Novartis
NIHR Clinical Research Network: Cancer
University of Leeds
Last reviewed: 18 May 2021
CRUK internal database number: 10533
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
